Literature DB >> 22801859

Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics.

Abdhish R Bhavsar, Cynthia R Stockdale, Frederick L Ferris, Alexander J Brucker, Neil M Bressler, Adam R Glassman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22801859      PMCID： PMC3489025          DOI： 10.1001/archophthalmol.2012.227

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  4 in total

1.  Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Authors:  Michael J Elman; Lloyd Paul Aiello; Roy W Beck; Neil M Bressler; Susan B Bressler; Allison R Edwards; Frederick L Ferris; Scott M Friedman; Adam R Glassman; Kellee M Miller; Ingrid U Scott; Cynthia R Stockdale; Jennifer K Sun
Journal:  Ophthalmology       Date:  2010-04-28       Impact factor: 12.079

2.  A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema.

Authors:  Ingrid U Scott; Allison R Edwards; Roy W Beck; Neil M Bressler; Clement K Chan; Michael J Elman; Scott M Friedman; Craig Michael Greven; Raj K Maturi; Dante J Pieramici; Michel Shami; Lawrence J Singerman; Cynthia R Stockdale
Journal:  Ophthalmology       Date:  2007-08-15       Impact factor: 12.079

3.  Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation.

Authors:  Joseph Googe; Alexander J Brucker; Neil M Bressler; Haijing Qin; Lloyd P Aiello; Andrew Antoszyk; Roy W Beck; Susan B Bressler; Frederick L Ferris; Adam R Glassman; Dennis Marcus; Cynthia R Stockdale
Journal:  Retina       Date:  2011-06       Impact factor: 4.256

4.  Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.

Authors:  Abdhish R Bhavsar; Joseph M Googe; Cynthia R Stockdale; Neil M Bressler; Alexander J Brucker; Michael J Elman; Adam R Glassman
Journal:  Arch Ophthalmol       Date:  2009-12
  4 in total
  26 in total

1.  Reply to Bhavsar et al.

Authors:  D A M Lyall; A Tey; B Foot; S T D Roxburgh; M Virdi; C Robertson; C J MacEwen
Journal:  Eye (Lond)       Date:  2013-10-18       Impact factor: 3.775

2.  Antibiotic prophylaxis for preventing endophthalmitis after intravitreal injection: a systematic review.

Authors:  Francesca Menchini; Giacomo Toneatto; Alba Miele; Simone Donati; Paolo Lanzetta; Gianni Virgili
Journal:  Eye (Lond)       Date:  2018-06-11       Impact factor: 3.775

3.  Post-injection endophthalmitis in eyes receiving vs. not receiving topical antibiotic prophylaxis in Northern Thailand.

Authors:  Voraporn Chaikitmongkol; Onnisa Nanegrungsunk; Direk Patikulsila; Janejit Choovuthayakorn; Nawat Watanachai; Paradee Kunavisarut; Nimitr Ittipunkul; Neil M Bressler
Journal:  Eye (Lond)       Date:  2018-08-14       Impact factor: 3.775

Review 4.  Prevention and treatment of injection-related endophthalmitis.

Authors:  Charles Q Yu; Christopher N Ta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-08       Impact factor: 3.117

5.  The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection.

Authors:  Philip Storey; Michael Dollin; Nadim Rayess; John Pitcher; Sahitya Reddy; James Vander; Jason Hsu; Sunir Garg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-05       Impact factor: 3.117

6.  Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT).

Authors:  Travis A Meredith; Colin A McCannel; Charles Barr; Bernard H Doft; Ellen Peskin; Maureen G Maguire; Daniel F Martin; Jonathan L Prenner
Journal:  Ophthalmology       Date:  2015-01-15       Impact factor: 12.079

7.  Risk of Infectious Endophthalmitis From a Resident-Performed Intravitreal Injection.

Authors:  H Russell Day; Janice C Law; Jennifer L Lindsey
Journal:  J Vitreoretin Dis       Date:  2020-12-10

8.  Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

Authors:  Stephen G Schwartz; Harry W Flynn
Journal:  Curr Ophthalmol Rep       Date:  2014-03-01

Review 9.  Ocular Infection: Endophthalmitis.

Authors:  Stephen G Schwartz; Harry W Flynn; Taraprasad Das; William F Mieler
Journal:  Dev Ophthalmol       Date:  2015-10-26

10.  Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti-Vascular Growth Factor Agents in a Nationwide Study in France.

Authors:  Florian Baudin; Eric Benzenine; Anne-Sophie Mariet; Alain M Bron; Vincent Daien; Jean François Korobelnik; Catherine Quantin; Catherine Creuzot-Garcher
Journal:  JAMA Ophthalmol       Date:  2018-12-01       Impact factor: 7.389
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.